Cresset Asset Management’s Korro Bio KRRO Stock Holding History

Cresset Asset Management’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-750	Closed	-$13.9K	–	1891
2023 Q3	$13.9K	Hold	750	–	–	﹤0.01%	1785
2023 Q2	$13K	Hold	750	–	–	﹤0.01%	1888
2023 Q1	$18.9K	Hold	750	–	–	﹤0.01%	804
2022 Q4	$144K	Hold	750	–	–	﹤0.01%	659
2022 Q3	$67K	Hold	750	–	–	﹤0.01%	848
2022 Q2	$56K	Hold	750	–	–	﹤0.01%	900
2022 Q1	$80K	Buy	750 +150	+25%	+$28.7K	﹤0.01%	957
2021 Q4	$154K	Buy	+600	New	+$182K	﹤0.01%	1071
2021 Q2	–	Sell	-600	Closed	-$285K	–	1051
2021 Q1	$285K	Sell	600 -150	-20%	-$291K	﹤0.01%	699
2020 Q4	$1.32M	Hold	750	–	–	0.02%	203
2020 Q3	$721K	Buy	750 +20	+3%	+$21.5K	0.01%	292
2020 Q2	$849K	Buy	+730	New	+$659K	0.02%	237

Other funds holding KRRO

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

QUSVM

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

7IH

72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cresset Asset Management's KRRO Position: Q4 2023 in Review

Cresset Asset Management sold out of Korro Bio (KRRO) in Q4 2023, closing a stake of 750 shares — an estimated $13.9K sold.

Cresset Asset Management first reported a position in KRRO in Q2 2020 and held it in 12 quarters. The position peaked at $1.32M in Q4 2020. 40 funds tracked by Wall St. Rank hold KRRO as of Q4 2023.

Cresset Asset Management reported no remaining Korro Bio position as of Q4 2023 after selling out during the quarter.
Cresset Asset Management sold 750 Korro Bio shares in Q4 2023, an estimated $13.9K.
Cresset Asset Management first reported a position in Korro Bio in Q2 2020 and held it in 12 quarters.
Cresset Asset Management's Korro Bio position peaked at $1.32M in Q4 2020.
40 funds tracked by Wall St. Rank held Korro Bio as of Q4 2023.

Based on Cresset Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.